Isis Pharmaceuticals, Inc.
|
 | ||||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
 |
return to message board, top of board |
Re: More on new lipid lowering strategiesArthur, if anything those descriptions are supportive of my points. MIpo will be limited to mainly HoFH and severe HeFH particularly if PCK9 drugs make it to market.
|
|||||||||||||||||||
|
|
return to message board, top of board |
| Msg # | Subject | Author | Recs | Date Posted |
| 26633 | Re: More on new lipid lowering strategies | arthurs1 | 6/3/2012 3:41:25 PM | |
